Resilient biomedical scientists experienced setbacks during the pandemic

When COVID-19 presented the world with the greatest health challenge in modern history, it was biomedical scientists who stepped up to develop diagnostic testing and vaccines to slow the spread of the disease.

Why Cannabis Stocks Continue Getting Clobbered

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter

May 29, 2023

Mundipharma receives positive opinion for candidiasis therapy

Invasive candidiasis is a severe infection of the bloodstream and/or deep or visceral tissues. Credit: Trzmiel / Shutterstock.com. Mundipharma and Cidara Therapeutics have received a

October 16, 2023

Risk Adjusted Net Present Value: What is the current valuation of Ultragenyx Pharmaceutical’s Rebisufligene Etisparvovec

The revenue for Rebisufligene Etisparvovec is expected to reach an annual total of $102 mn by 2038 globally based off GlobalData’s Expiry Model. The drug’s

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.